首页 > 最新文献

Experimental hematology最新文献

英文 中文
2011 – THE EMBRYONIC HEART AS A TRANSIENT HEMATOPOIETIC SITE FOR MACROPHAGE-MEDIATED CARDIAC REMODELING 2011 -胚胎心脏作为巨噬细胞介导的心脏重塑的瞬时造血位点
IF 2.1 4区 医学 Q2 HEMATOLOGY Pub Date : 2025-11-01 DOI: 10.1016/j.exphem.2025.104924
Norika Liu , Atsushi Nakano
The cells that comprise the circulatory system not only share developmental origins but also mutually support each other’s differentiation during early embryogenesis. Although classical models attribute embryonic hematopoiesis in mammals to the yolk sac and aorta-gonad-mesonephros (AGM) region, we and others have identified the embryonic heart as a transient hematopoietic niche. A subset of endocardial cells in the outflow tract and atrioventricular canal undergo endothelial-to-hematopoietic transition (EHT) in an Nkx2-5-dependent manner, mirroring the tinman-regulated cardio-hematopoietic program in Drosophila. These hemogenic endocardial cells, enriched in the cushion region—the primordia of cardiac valves and septa—not only contribute to local hematopoiesis but also give rise to tissue macrophages that facilitate valve morphogenesis.
These findings challenge the traditional view of hematopoietic compartmentalization and establish a novel paradigm in which the heart itself contributes to hematopoietic development. Using lineage tracing and knockout mouse models, we further show that endocardial-derived macrophages persist into adulthood as tissue-resident macrophages, particularly within cardiac valves and vasculature. Functionally, these cells appear to modulate tissue homeostasis and suppress pathological fibrosis.
In summary, our study reveals that the embryonic heart acts as a local hematopoietic organ, supplying a distinct macrophage population that contributes to both cardiac morphogenesis and long-term homeostasis. These insights broaden our understanding of the interplay between hematopoiesis and cardiogenesis and suggest new avenues for investigating tissue-resident immune cell ontogeny.
构成循环系统的细胞不仅具有共同的发育起源,而且在早期胚胎发生过程中相互支持彼此的分化。尽管经典模型将哺乳动物胚胎造血归因于卵黄囊和主动脉-性腺-中肾(AGM)区域,但我们和其他人已经确定胚胎心脏是一个短暂的造血生态位。流出道和房室管中的心内膜细胞亚群以nkx2 -5依赖的方式经历内皮到造血的转变(EHT),反映了果蝇中锡蛋白调节的心脏造血程序。这些造血心内膜细胞富集于缓冲区(心脏瓣膜和间隔的原基),不仅有助于局部造血,还能产生促进瓣膜形态发生的组织巨噬细胞。这些发现挑战了造血区隔的传统观点,并建立了心脏本身有助于造血发育的新范式。通过谱系追踪和敲除小鼠模型,我们进一步表明心内膜源性巨噬细胞作为组织内巨噬细胞持续存在于成年期,特别是在心脏瓣膜和脉管系统内。功能上,这些细胞似乎调节组织稳态并抑制病理性纤维化。总之,我们的研究表明,胚胎心脏作为局部造血器官,提供独特的巨噬细胞群,有助于心脏形态发生和长期稳态。这些见解拓宽了我们对造血和心脏发生之间相互作用的理解,并为研究组织驻留免疫细胞的个体发生提供了新的途径。
{"title":"2011 – THE EMBRYONIC HEART AS A TRANSIENT HEMATOPOIETIC SITE FOR MACROPHAGE-MEDIATED CARDIAC REMODELING","authors":"Norika Liu ,&nbsp;Atsushi Nakano","doi":"10.1016/j.exphem.2025.104924","DOIUrl":"10.1016/j.exphem.2025.104924","url":null,"abstract":"<div><div>The cells that comprise the circulatory system not only share developmental origins but also mutually support each other’s differentiation during early embryogenesis. Although classical models attribute embryonic hematopoiesis in mammals to the yolk sac and aorta-gonad-mesonephros (AGM) region, we and others have identified the embryonic heart as a transient hematopoietic niche. A subset of endocardial cells in the outflow tract and atrioventricular canal undergo endothelial-to-hematopoietic transition (EHT) in an Nkx2-5-dependent manner, mirroring the tinman-regulated cardio-hematopoietic program in Drosophila. These hemogenic endocardial cells, enriched in the cushion region—the primordia of cardiac valves and septa—not only contribute to local hematopoiesis but also give rise to tissue macrophages that facilitate valve morphogenesis.</div><div>These findings challenge the traditional view of hematopoietic compartmentalization and establish a novel paradigm in which the heart itself contributes to hematopoietic development. Using lineage tracing and knockout mouse models, we further show that endocardial-derived macrophages persist into adulthood as tissue-resident macrophages, particularly within cardiac valves and vasculature. Functionally, these cells appear to modulate tissue homeostasis and suppress pathological fibrosis.</div><div>In summary, our study reveals that the embryonic heart acts as a local hematopoietic organ, supplying a distinct macrophage population that contributes to both cardiac morphogenesis and long-term homeostasis. These insights broaden our understanding of the interplay between hematopoiesis and cardiogenesis and suggest new avenues for investigating tissue-resident immune cell ontogeny.</div></div>","PeriodicalId":12202,"journal":{"name":"Experimental hematology","volume":"151 ","pages":"Article 104924"},"PeriodicalIF":2.1,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145620047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2017 – ANCIENT GENOMIC LINKAGE OF NPRL3 AND Α-GLOBIN COUPLES METABOLISM WITH ERYTHROID DEVELOPMENT 2017 - nprl3和Α-globin与红细胞发育代谢的古老基因组联系
IF 2.1 4区 医学 Q2 HEMATOLOGY Pub Date : 2025-11-01 DOI: 10.1016/j.exphem.2025.104930
Alexandra Preston , Joe Frost , Megan Teh , Mohsin Badat , Andrew Armitage , Ruggiero Norfo , Sarah Wideman , Muhammad Hanifi , Natasha White , Noemi Roy , Christian Babbs , Bart Ghesquiere , James Davies , Andrew Howden , Linda Sinclair , Jim Hughes , Mira Kassouf , Robert Beagrie , Douglas Higgs , Hal Drakesmith
α-globin’s genomic next-door neighbor, Nprl3, contains 4 of the 5 α-globin enhancers. Nprl3 negatively regulates mTORC1, a master controller of cell metabolism. Nprl3, α-globin, and the α-globin enhancers have been colocated for >500 million years. However, the function of this genomic linkage is unknown.
Using a mouse in which the Nprl3 promoter is deleted (with no effect on the α-globin enhancers), we showed that Nprl3 is required for optimal erythropoiesis in fetal liver and bone marrow. On embryonic day 13.5 (E13.5) in the fetal liver, Nprl3−/− erythroid cells failed to develop beyond the proerythroblast stage. Metabolite profiling, RNA-Seq and proteomics showed that Nprl3−/− erythroblasts have overactivated mTORC1 signaling, overcharged glycolysis, and suppressed autophagy. Competitive bone marrow-fetal liver chimeras indicated a hematopoietic-intrinsic Nprl3 requirement for erythropoiesis. To study human erythropoiesis, we induced NPRL3-knockout by RNP-editing primary CD34+ cells. Edited progenitors produced fewer enucleated erythroid cells and exhibited defective mTORC1 signaling responses to fluctuating iron, amino acid, and erythropoietin (EPO) availability. Nprl3 tunes the metabolism of developing erythroid cells to their nutritional environment.
Nprl3 expression is highly elevated in erythroid cells. We showed that this is due to the interaction between the Nprl3 promoter and α-globin enhancers. We eliminated interactions (in cis) between Nprl3 and the enhancers, while maintaining enhancer control of α-globin. Remarkably, our approach resulted in erythropoietic impairment reminiscent of the Nprl3−/− genotype (with E13.5 erythroid development inhibited at the same stage of differentiation). Therefore, the ancient transcriptional hub of Nprl3, α-globin, and their enhancers supports the erythroid-specific upregulation of Nprl3 and coordinates metabolic control with red blood cell development.
α-珠蛋白的基因组邻居Nprl3包含5个α-珠蛋白增强子中的4个。Nprl3负调控mTORC1, mTORC1是细胞代谢的主要控制因子。Nprl3、α-珠蛋白和α-珠蛋白增强子已经共存了5亿年。然而,这种基因组连锁的功能尚不清楚。在缺失Nprl3启动子的小鼠中(对α-珠蛋白增强子没有影响),我们发现Nprl3是胎儿肝脏和骨髓中最佳红细胞生成所必需的。在胚胎第13.5天(E13.5), Nprl3−/−红细胞不能发育到原红细胞阶段。代谢物分析、RNA-Seq和蛋白质组学显示,Nprl3−/−红细胞过度激活mTORC1信号,过度充能糖酵解,抑制自噬。竞争性骨髓-胎肝嵌合体表明造血内生性Nprl3对红细胞生成的需求。为了研究人类红细胞生成,我们用rnp编辑的原代CD34+细胞诱导nprl3敲除。编辑过的祖细胞产生较少的去核红细胞,并且对波动的铁、氨基酸和促红细胞生成素(EPO)的可用性表现出缺陷的mTORC1信号反应。Nprl3调节发育中的红系细胞对其营养环境的代谢。Nprl3在红系细胞中的表达高度升高。我们发现这是由于Nprl3启动子和α-珠蛋白增强子之间的相互作用。我们消除了Nprl3和增强子之间的相互作用(顺式),同时维持了增强子对α-珠蛋白的控制。值得注意的是,我们的方法导致了与Nprl3 - / -基因型相似的红细胞生成障碍(E13.5红细胞发育在同一分化阶段受到抑制)。因此,Nprl3的古老转录中枢α-珠蛋白及其增强子支持Nprl3的红细胞特异性上调,并协调红细胞发育的代谢控制。
{"title":"2017 – ANCIENT GENOMIC LINKAGE OF NPRL3 AND Α-GLOBIN COUPLES METABOLISM WITH ERYTHROID DEVELOPMENT","authors":"Alexandra Preston ,&nbsp;Joe Frost ,&nbsp;Megan Teh ,&nbsp;Mohsin Badat ,&nbsp;Andrew Armitage ,&nbsp;Ruggiero Norfo ,&nbsp;Sarah Wideman ,&nbsp;Muhammad Hanifi ,&nbsp;Natasha White ,&nbsp;Noemi Roy ,&nbsp;Christian Babbs ,&nbsp;Bart Ghesquiere ,&nbsp;James Davies ,&nbsp;Andrew Howden ,&nbsp;Linda Sinclair ,&nbsp;Jim Hughes ,&nbsp;Mira Kassouf ,&nbsp;Robert Beagrie ,&nbsp;Douglas Higgs ,&nbsp;Hal Drakesmith","doi":"10.1016/j.exphem.2025.104930","DOIUrl":"10.1016/j.exphem.2025.104930","url":null,"abstract":"<div><div>α-globin’s genomic next-door neighbor, Nprl3, contains 4 of the 5 α-globin enhancers. Nprl3 negatively regulates mTORC1, a master controller of cell metabolism. Nprl3, α-globin, and the α-globin enhancers have been colocated for &gt;500 million years. However, the function of this genomic linkage is unknown.</div><div>Using a mouse in which the Nprl3 promoter is deleted (with no effect on the α-globin enhancers), we showed that Nprl3 is required for optimal erythropoiesis in fetal liver and bone marrow. On embryonic day 13.5 (E13.5) in the fetal liver, Nprl3−/− erythroid cells failed to develop beyond the proerythroblast stage. Metabolite profiling, RNA-Seq and proteomics showed that Nprl3−/− erythroblasts have overactivated mTORC1 signaling, overcharged glycolysis, and suppressed autophagy. Competitive bone marrow-fetal liver chimeras indicated a hematopoietic-intrinsic Nprl3 requirement for erythropoiesis. To study human erythropoiesis, we induced NPRL3-knockout by RNP-editing primary CD34+ cells. Edited progenitors produced fewer enucleated erythroid cells and exhibited defective mTORC1 signaling responses to fluctuating iron, amino acid, and erythropoietin (EPO) availability. Nprl3 tunes the metabolism of developing erythroid cells to their nutritional environment.</div><div>Nprl3 expression is highly elevated in erythroid cells. We showed that this is due to the interaction between the Nprl3 promoter and α-globin enhancers. We eliminated interactions (in cis) between Nprl3 and the enhancers, while maintaining enhancer control of α-globin. Remarkably, our approach resulted in erythropoietic impairment reminiscent of the Nprl3−/− genotype (with E13.5 erythroid development inhibited at the same stage of differentiation). Therefore, the ancient transcriptional hub of Nprl3, α-globin, and their enhancers supports the erythroid-specific upregulation of Nprl3 and coordinates metabolic control with red blood cell development.</div></div>","PeriodicalId":12202,"journal":{"name":"Experimental hematology","volume":"151 ","pages":"Article 104930"},"PeriodicalIF":2.1,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145620065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2015 – MENIN ORCHESTRATES EXPRESSION OF THE MASTER PLASMA CELL TRANSCRIPTION FACTOR IRF4 AND IS AN ACTIONABLE TARGET IN MULTIPLE MYELOMA. 2015 - menin调控主浆细胞转录因子irf4的表达,是多发性骨髓瘤的一个可操作靶点。
IF 2.1 4区 医学 Q2 HEMATOLOGY Pub Date : 2025-11-01 DOI: 10.1016/j.exphem.2025.104928
Lev Kats , Emily Gruber , Sree Kumar , Rheana Franich , Omer Gilan , Tiffany Khong , Andrew Spencer
Multiple myeloma (MM) is a common plasma cell malignancy that remains mostly incurable. We analyzed the Cancer Gene Dependency Map and identified menin as a therapeutically actionable MM vulnerability. Gene knockout and menin inhibitor (iMenin) therapy experiments across an extensive panel of MM cell lines confirmed that ∼20% are highly sensitive to menin disruption, with an additional ∼40% demonstrating a partial response. Similar findings were also made in a separate custom panel of early passage MM lines that more closely recapitulate genetic alterations found in patients with MM.
Gene expression and chromatin profiling studies in iMenin-sensitive, intermediate, and refractory MM lines identified the master myeloma cell identity factor IRF4 as the major downstream target of menin inhibition. iMenin-sensitive lines are characterized by abundant deposition of the menin/MLL1 complex at the super-enhancer of IRF4, with iMenin treatment resulting in eviction of menin/MLL1 from chromatin and concomitant suppression of IRF4 and its target genes. Interestingly, iMenin sensitivity in MM also correlates with transcriptional signatures of immature B cells that are, in turn, inversely correlated with response to many current treatments, especially those that target the B-cell maturation antigen (BCMA).
In parallel, we also applied genome-wide CRISPR screening, which implicated the CREBBP/EP300/NCOR1 axis as a key modulator of iMenin sensitivity. Notably, clinical-grade menin and EP300 inhibitors demonstrated synergistic activity against primary patients with MM samples cultured ex vivo and against the syngeneic Vk*MYC MM model in vivo. Molecular analysis revealed deep and synergistic suppression of IRF4 potentiated by the combination. Altogether, our comprehensive study identified menin as a promising target in MM and charts potential paths for rapid clinical translation.
多发性骨髓瘤(MM)是一种常见的浆细胞恶性肿瘤,大多数是无法治愈的。我们分析了癌症基因依赖图谱,并确定menin是一种可治疗的MM易感性。基因敲除和menin抑制剂(iMenin)治疗实验在广泛的MM细胞系面板上证实,约20%对menin中断高度敏感,另外约40%显示部分反应。在早期传代MM细胞系的单独定制小组中也有类似的发现,该小组更接近地概括了MM患者的遗传改变。对imenin敏感、中间和难耐MM细胞系的基因表达和染色质谱研究发现,主骨髓瘤细胞身份因子IRF4是menin抑制的主要下游靶点。iMenin敏感系的特点是在IRF4超增强子处大量沉积menin/MLL1复合物,iMenin处理导致menin/MLL1从染色质中被清除,同时抑制IRF4及其靶基因。有趣的是,MM中的iMenin敏感性也与未成熟B细胞的转录特征相关,而这些转录特征反过来又与对许多当前治疗的反应呈负相关,特别是针对B细胞成熟抗原(BCMA)的治疗。同时,我们还应用了全基因组CRISPR筛选,发现CREBBP/EP300/NCOR1轴是iMenin敏感性的关键调节因子。值得注意的是,临床级menin和EP300抑制剂对体外培养的MM样品的原发患者和体内的同源Vk*MYC MM模型显示出协同作用。分子分析显示,这两种组合对IRF4有深度的协同抑制作用。总之,我们的综合研究确定了menin是MM的一个有希望的靶点,并绘制了快速临床转化的潜在途径。
{"title":"2015 – MENIN ORCHESTRATES EXPRESSION OF THE MASTER PLASMA CELL TRANSCRIPTION FACTOR IRF4 AND IS AN ACTIONABLE TARGET IN MULTIPLE MYELOMA.","authors":"Lev Kats ,&nbsp;Emily Gruber ,&nbsp;Sree Kumar ,&nbsp;Rheana Franich ,&nbsp;Omer Gilan ,&nbsp;Tiffany Khong ,&nbsp;Andrew Spencer","doi":"10.1016/j.exphem.2025.104928","DOIUrl":"10.1016/j.exphem.2025.104928","url":null,"abstract":"<div><div>Multiple myeloma (MM) is a common plasma cell malignancy that remains mostly incurable. We analyzed the Cancer Gene Dependency Map and identified menin as a therapeutically actionable MM vulnerability. Gene knockout and menin inhibitor (iMenin) therapy experiments across an extensive panel of MM cell lines confirmed that ∼20% are highly sensitive to menin disruption, with an additional ∼40% demonstrating a partial response. Similar findings were also made in a separate custom panel of early passage MM lines that more closely recapitulate genetic alterations found in patients with MM.</div><div>Gene expression and chromatin profiling studies in iMenin-sensitive, intermediate, and refractory MM lines identified the master myeloma cell identity factor IRF4 as the major downstream target of menin inhibition. iMenin-sensitive lines are characterized by abundant deposition of the menin/MLL1 complex at the super-enhancer of IRF4, with iMenin treatment resulting in eviction of menin/MLL1 from chromatin and concomitant suppression of IRF4 and its target genes. Interestingly, iMenin sensitivity in MM also correlates with transcriptional signatures of immature B cells that are, in turn, inversely correlated with response to many current treatments, especially those that target the B-cell maturation antigen (BCMA).</div><div>In parallel, we also applied genome-wide CRISPR screening, which implicated the CREBBP/EP300/NCOR1 axis as a key modulator of iMenin sensitivity. Notably, clinical-grade menin and EP300 inhibitors demonstrated synergistic activity against primary patients with MM samples cultured ex vivo and against the syngeneic Vk*MYC MM model in vivo. Molecular analysis revealed deep and synergistic suppression of IRF4 potentiated by the combination. Altogether, our comprehensive study identified menin as a promising target in MM and charts potential paths for rapid clinical translation.</div></div>","PeriodicalId":12202,"journal":{"name":"Experimental hematology","volume":"151 ","pages":"Article 104928"},"PeriodicalIF":2.1,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145620058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2009 – MAST CELLS SUPPORT HEMATOPOIETIC STEM CELL FUNCTION DURING THE TRANSITION TO BONE MARROW HEMATOPOIESIS 2009年-肥大细胞在向骨髓造血过渡的过程中支持造血干细胞功能
IF 2.1 4区 医学 Q2 HEMATOLOGY Pub Date : 2025-11-01 DOI: 10.1016/j.exphem.2025.104922
Zining Yang, Hui Cheng, Tao Cheng, Can Li, Jingxuan Li, Ruixia Sun
The developmental transition from early embryonic hematopoiesis to adult bone marrow hematopoiesis is a complex process that remains poorly understood. In particular, the cellular composition and regulatory mechanisms of the microenvironment during the initial engraftment and establishment of hematopoietic stem cells (HSCs) in the bone marrow are unclear. Understanding these niche components is essential to reveal how hematopoiesis develops and adapts.
In this study, we identify a previously unrecognized population of mature mast cells transiently present across multiple hematopoietic organs—including liver, spleen, and bone marrow—during early bone marrow hematopoiesis in both humans and mice.
These mast cells display distinct molecular markers and mature granule morphology, indicating their functional activity. Using in vitro coculture experiments, we show that mast cells directly support HSC function through the secretion of serotonin (5-HT). Depletion of mast cells during the perinatal period leads to significantly reduced 5-HT levels in the spleen and a marked decrease in hematopoietic stem and progenitor cell (HSPC) numbers. This reveals a critical role for mast cell-derived serotonin in regulating early hematopoiesis. We also provide transcriptomic profiles of mast cells from neonatal mouse hematopoietic tissues, expanding the cross-tissue transcriptomic atlas of mouse mast cells and revealing specialized gene expression signatures linked to their developmental function.
Together, these findings have revealed the new role of mast cells in supporting hematopoiesis during specific developmental windows, highlighting their significance as microenvironment regulators in the early hematopoietic development of both humans and mice.
从早期胚胎造血到成人骨髓造血的发育转变是一个复杂的过程,目前尚不清楚。特别是造血干细胞(HSCs)在骨髓中初始植入和建立过程中微环境的细胞组成和调控机制尚不清楚。了解这些生态位成分对于揭示造血系统是如何发展和适应的至关重要。在这项研究中,我们在人类和小鼠的早期骨髓造血过程中发现了一种以前未被识别的成熟肥大细胞群,它们在多个造血器官(包括肝脏、脾脏和骨髓)中短暂存在。这些肥大细胞表现出独特的分子标记和成熟的颗粒形态,表明它们具有功能活性。通过体外共培养实验,我们发现肥大细胞通过分泌血清素(5-HT)直接支持HSC功能。围产期肥大细胞耗竭导致脾脏5-HT水平显著降低,造血干细胞和祖细胞(HSPC)数量显著减少。这揭示了肥大细胞衍生的血清素在调节早期造血中的关键作用。我们还提供了来自新生小鼠造血组织的肥大细胞的转录组图谱,扩展了小鼠肥大细胞的跨组织转录组图谱,揭示了与其发育功能相关的特殊基因表达特征。总之,这些发现揭示了肥大细胞在特定发育窗口期支持造血的新作用,强调了它们在人类和小鼠早期造血发育中作为微环境调节剂的重要性。
{"title":"2009 – MAST CELLS SUPPORT HEMATOPOIETIC STEM CELL FUNCTION DURING THE TRANSITION TO BONE MARROW HEMATOPOIESIS","authors":"Zining Yang,&nbsp;Hui Cheng,&nbsp;Tao Cheng,&nbsp;Can Li,&nbsp;Jingxuan Li,&nbsp;Ruixia Sun","doi":"10.1016/j.exphem.2025.104922","DOIUrl":"10.1016/j.exphem.2025.104922","url":null,"abstract":"<div><div>The developmental transition from early embryonic hematopoiesis to adult bone marrow hematopoiesis is a complex process that remains poorly understood. In particular, the cellular composition and regulatory mechanisms of the microenvironment during the initial engraftment and establishment of hematopoietic stem cells (HSCs) in the bone marrow are unclear. Understanding these niche components is essential to reveal how hematopoiesis develops and adapts.</div><div>In this study, we identify a previously unrecognized population of mature mast cells transiently present across multiple hematopoietic organs—including liver, spleen, and bone marrow—during early bone marrow hematopoiesis in both humans and mice.</div><div>These mast cells display distinct molecular markers and mature granule morphology, indicating their functional activity. Using in vitro coculture experiments, we show that mast cells directly support HSC function through the secretion of serotonin (5-HT). Depletion of mast cells during the perinatal period leads to significantly reduced 5-HT levels in the spleen and a marked decrease in hematopoietic stem and progenitor cell (HSPC) numbers. This reveals a critical role for mast cell-derived serotonin in regulating early hematopoiesis. We also provide transcriptomic profiles of mast cells from neonatal mouse hematopoietic tissues, expanding the cross-tissue transcriptomic atlas of mouse mast cells and revealing specialized gene expression signatures linked to their developmental function.</div><div>Together, these findings have revealed the new role of mast cells in supporting hematopoiesis during specific developmental windows, highlighting their significance as microenvironment regulators in the early hematopoietic development of both humans and mice.</div></div>","PeriodicalId":12202,"journal":{"name":"Experimental hematology","volume":"151 ","pages":"Article 104922"},"PeriodicalIF":2.1,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145620171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
1026 – CELLULAR PLASTICITY DRIVES PERSISTENCE AND RESISTANCE OF LEUKEMIA CELLS UNDER MENIN INHIBITOR TREATMENT 细胞可塑性驱动白血病细胞在menin抑制剂治疗下的持久性和耐药性
IF 2.1 4区 医学 Q2 HEMATOLOGY Pub Date : 2025-11-01 DOI: 10.1016/j.exphem.2025.104906
Florian Perner
The mixed lineage leukemia (KMT2A/MLL1) gene is critical for hematopoiesis, but its translocation drives aggressive, treatment-resistant leukemias in infants and adults. Although previous targeted strategies showed limited efficacy, the recent development of menin inhibitors, disrupting the KMT2A-menin interaction, demonstrated significant promise. However, therapeutic resistance to these menin inhibitors emerges rapidly under monotherapy, highlighting a critical challenge and the need for deeper molecular understanding to guide intervention. A critical distinction between this class of compounds and conventional chemotherapeutic agents or apoptosis-inducing drugs like venetoclax lies in their mechanism of action. Unlike these agents, which typically trigger rapid cell death, menin inhibitors do not induce immediate cytotoxicity. Instead, they alleviate the differentiation blockade by reprogramming aberrant oncogenic chromatin states. As a result, the time to achieve the best clinical response is prolonged, with leukemia cells persisting for weeks to months in both preclinical models and early-phase clinical trials. During this extended period of persistence, leukemia cells undergo a complex adaptive process, transitioning into a drug-tolerant persister state that enables them to withstand therapeutic pressure. Interestingly, the molecular signatures of these persister cells closely resemble those observed in drug-tolerant cancer cells across other tumor types, suggesting a conserved mechanism of cellular plasticity that transcends cancer subtypes and treatment modalities. In leukemia, this adaptive state is characterized by cellular dormancy and the emergence of transcriptional and immunophenotypic features indicative of myeloid differentiation. These findings underscore a significant clinical challenge: in this context, defining the tipping point between a cell retaining leukemogenic potential and a terminally differentiated cell in diagnostic assays becomes difficult, if not impossible. This ambiguity highlights the need for more precise biomarkers to monitor therapeutic responses and predict clinical outcomes in patients treated with menin inhibitors.
混合谱系白血病(KMT2A/MLL1)基因对造血至关重要,但其易位会导致婴儿和成人的侵袭性、治疗抵抗性白血病。尽管先前的靶向策略显示出有限的疗效,但最近开发的menin抑制剂,破坏KMT2A-menin相互作用,显示出重大的希望。然而,在单一治疗下,对这些menin抑制剂的治疗耐药性迅速出现,这突出了一个关键的挑战,需要更深入的分子理解来指导干预。这类化合物与传统化疗药物或诱导细胞凋亡的药物(如venetoclax)的关键区别在于它们的作用机制。与这些通常会引发细胞快速死亡的药物不同,menin抑制剂不会立即诱导细胞毒性。相反,它们通过重新编程异常的致癌染色质状态来缓解分化阻断。因此,达到最佳临床反应的时间被延长了,白血病细胞在临床前模型和早期临床试验中都能持续数周到数月。在这段持续时间内,白血病细胞经历了一个复杂的适应过程,过渡到耐药持续状态,使它们能够承受治疗压力。有趣的是,这些持久性细胞的分子特征与在其他肿瘤类型的耐药癌细胞中观察到的分子特征非常相似,这表明细胞可塑性的保守机制超越了癌症亚型和治疗方式。在白血病中,这种适应状态的特点是细胞休眠,并出现指示髓细胞分化的转录和免疫表型特征。这些发现强调了一个重要的临床挑战:在这种情况下,在诊断分析中定义保留白血病潜能的细胞和终末分化细胞之间的临界点变得困难,如果不是不可能的话。这种模糊性突出了需要更精确的生物标志物来监测治疗反应并预测接受menin抑制剂治疗的患者的临床结果。
{"title":"1026 – CELLULAR PLASTICITY DRIVES PERSISTENCE AND RESISTANCE OF LEUKEMIA CELLS UNDER MENIN INHIBITOR TREATMENT","authors":"Florian Perner","doi":"10.1016/j.exphem.2025.104906","DOIUrl":"10.1016/j.exphem.2025.104906","url":null,"abstract":"<div><div>The mixed lineage leukemia (KMT2A/MLL1) gene is critical for hematopoiesis, but its translocation drives aggressive, treatment-resistant leukemias in infants and adults. Although previous targeted strategies showed limited efficacy, the recent development of menin inhibitors, disrupting the KMT2A-menin interaction, demonstrated significant promise. However, therapeutic resistance to these menin inhibitors emerges rapidly under monotherapy, highlighting a critical challenge and the need for deeper molecular understanding to guide intervention. A critical distinction between this class of compounds and conventional chemotherapeutic agents or apoptosis-inducing drugs like venetoclax lies in their mechanism of action. Unlike these agents, which typically trigger rapid cell death, menin inhibitors do not induce immediate cytotoxicity. Instead, they alleviate the differentiation blockade by reprogramming aberrant oncogenic chromatin states. As a result, the time to achieve the best clinical response is prolonged, with leukemia cells persisting for weeks to months in both preclinical models and early-phase clinical trials. During this extended period of persistence, leukemia cells undergo a complex adaptive process, transitioning into a drug-tolerant persister state that enables them to withstand therapeutic pressure. Interestingly, the molecular signatures of these persister cells closely resemble those observed in drug-tolerant cancer cells across other tumor types, suggesting a conserved mechanism of cellular plasticity that transcends cancer subtypes and treatment modalities. In leukemia, this adaptive state is characterized by cellular dormancy and the emergence of transcriptional and immunophenotypic features indicative of myeloid differentiation. These findings underscore a significant clinical challenge: in this context, defining the tipping point between a cell retaining leukemogenic potential and a terminally differentiated cell in diagnostic assays becomes difficult, if not impossible. This ambiguity highlights the need for more precise biomarkers to monitor therapeutic responses and predict clinical outcomes in patients treated with menin inhibitors.</div></div>","PeriodicalId":12202,"journal":{"name":"Experimental hematology","volume":"151 ","pages":"Article 104906"},"PeriodicalIF":2.1,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145620269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3033 – ATLAS OF CYNOMOLGUS MACAQUE HEMATOPOIESIS 3033 -食蟹猴造血图谱
IF 2.1 4区 医学 Q2 HEMATOLOGY Pub Date : 2025-11-01 DOI: 10.1016/j.exphem.2025.104974
Ryo Yamamoto
Self-renewal and differentiation are inherent properties of hematopoietic stem cells (HSCs) that are necessary to support hematopoiesis; however, the underlying mechanisms, especially in humans, remain unclear. Here, using the cynomolgus macaque as a surrogate model, we develop a new gating strategy to isolate with high purity transplantable cynomolgus HSCs and generate a single-cell transcriptomic map of cynomolgus HSCs and progenitor cells—covering gestational periods previously not analyzed in humans.
We performed single-cell transcriptomic analysis using 10 × genomics and Smart-seq technologies. This study presents a single-cell transcriptomic analysis of CD34hi hematopoietic stem and progenitor cells (HSPCs) from cynomolgus monkeys across developmental stages—fetal liver, fetal bone marrow, and adult bone marrow. We found that there are dynamic shifts in HSPC composition with development: HSC/MPP frequencies peak in late second trimester and decrease with age, whereas myeloid and lymphoid progenitors increase and erythroid/megakaryocyte lineages decline. Developmental and tissue-specific gene expression differences were identified in HSCs, such as higher mitochondrial activity in fetal HSCs and NF-κB–related genes in aged ABM-HSCs. Furthermore, novel surface markers for transcriptionally purified HSCs were identified, offering improved tools for future HSC isolation. We anticipate that our comprehensive data set will serve as a basis for building an HSC atlas of cynomolgus monkeys that will facilitate a better understanding of conserved and nonconserved properties as well as mechanisms between nonhuman primates (NHPs) and humans, which will be necessary for better translational applications in the future.
自我更新和分化是造血干细胞(hsc)的固有特性,是支持造血所必需的;然而,潜在的机制,特别是在人类中,仍然不清楚。本研究以食蟹猕猴作为替代模型,开发了一种新的门控策略,分离出高纯度可移植的食蟹造血干细胞,并生成了覆盖人类妊娠期的食蟹造血干细胞和祖细胞的单细胞转录组图谱。我们使用10 × 基因组学和Smart-seq技术进行单细胞转录组学分析。本研究对食蟹猴不同发育阶段(胎儿肝脏、胎儿骨髓和成年骨髓)的造血干细胞和祖细胞(HSPCs)进行了单细胞转录组学分析。我们发现,随着发育,HSPC组成存在动态变化:HSC/MPP频率在妊娠中期达到峰值,并随着年龄的增长而下降,而髓系和淋巴系祖细胞增加,红细胞/巨核细胞谱系减少。在造血干细胞中发现了发育和组织特异性基因表达差异,例如胎儿造血干细胞中线粒体活性较高,老年abm -造血干细胞中NF-κ b相关基因较高。此外,还发现了转录纯化HSC的新表面标记,为未来HSC的分离提供了改进的工具。我们预计,我们的综合数据集将作为构建食蟹猴HSC图谱的基础,这将有助于更好地理解非人类灵长类动物(NHPs)与人类之间的保守和非保守特性以及机制,这将是未来更好的翻译应用所必需的。
{"title":"3033 – ATLAS OF CYNOMOLGUS MACAQUE HEMATOPOIESIS","authors":"Ryo Yamamoto","doi":"10.1016/j.exphem.2025.104974","DOIUrl":"10.1016/j.exphem.2025.104974","url":null,"abstract":"<div><div>Self-renewal and differentiation are inherent properties of hematopoietic stem cells (HSCs) that are necessary to support hematopoiesis; however, the underlying mechanisms, especially in humans, remain unclear. Here, using the cynomolgus macaque as a surrogate model, we develop a new gating strategy to isolate with high purity transplantable cynomolgus HSCs and generate a single-cell transcriptomic map of cynomolgus HSCs and progenitor cells—covering gestational periods previously not analyzed in humans.</div><div>We performed single-cell transcriptomic analysis using 10 × genomics and Smart-seq technologies. This study presents a single-cell transcriptomic analysis of CD34hi hematopoietic stem and progenitor cells (HSPCs) from cynomolgus monkeys across developmental stages—fetal liver, fetal bone marrow, and adult bone marrow. We found that there are dynamic shifts in HSPC composition with development: HSC/MPP frequencies peak in late second trimester and decrease with age, whereas myeloid and lymphoid progenitors increase and erythroid/megakaryocyte lineages decline. Developmental and tissue-specific gene expression differences were identified in HSCs, such as higher mitochondrial activity in fetal HSCs and NF-κB–related genes in aged ABM-HSCs. Furthermore, novel surface markers for transcriptionally purified HSCs were identified, offering improved tools for future HSC isolation. We anticipate that our comprehensive data set will serve as a basis for building an HSC atlas of cynomolgus monkeys that will facilitate a better understanding of conserved and nonconserved properties as well as mechanisms between nonhuman primates (NHPs) and humans, which will be necessary for better translational applications in the future.</div></div>","PeriodicalId":12202,"journal":{"name":"Experimental hematology","volume":"151 ","pages":"Article 104974"},"PeriodicalIF":2.1,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145620398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3034 – IN VITRO INDUCTION OF HEMATOPOIETIC STEM CELLS FROM EARLY HEMOGENIC ENDOTHELIAL CELLS 3034 -早期造血内皮细胞体外诱导造血干细胞
IF 2.1 4区 医学 Q2 HEMATOLOGY Pub Date : 2025-11-01 DOI: 10.1016/j.exphem.2025.104975
Mariko Tsuruda , Saori Morino-Koga , Xueyu Zhao , Shingo Usuki , Kei-ichiro Yasunaga , Tomomasa Yokomizo , Ryuichi Nishinakamura , Toshio Suda , Minetaro Ogawa
During embryogenesis, hematopoietic stem cells (HSCs) arise from hemogenic endothelial cells (HECs). HECs enter endothelial-to-hematopoietic transition (EHT) and differentiate into HSCs via pre-HSCs. Previously, we reported that two cytokines and feeder cells were sufficient to induce HSCs from HECs and pre-HSCs isolated from mouse embryos at embryonic day 10.5 (E10.5). However, the signaling requirements at earlier developmental stages remain largely undefined. In this study, we sought to identify the key signaling factors required to induce HSCs from E9.5 HECs in vitro. Transcriptomic profiling of E9.5 mouse embryos detected activation of bone morphogenetic protein (BMP) signaling in HECs. BMP4 treatment in the culture system enhanced the generation of multilineage hematopoietic colonies and long-term repopulating HSCs, as confirmed using colony-forming and transplantation assays. Furthermore, early-stage HECs capable of forming HSCs expressed the BMP4 receptor. These results suggest that BMP4 plays a key role in promoting the emergence of transplantable HSCs from early HECs and provides insight into stage-specific requirements for HSC development. These findings may contribute to establishing conditions for in vitro derivation of HSCs from pluripotent stem cells.
在胚胎发生过程中,造血干细胞(hsc)由造血内皮细胞(HECs)产生。hec进入内皮到造血转化(EHT),并通过造血干细胞前分化为造血干细胞。此前,我们报道了两种细胞因子和饲养细胞足以在胚胎10.5天(E10.5)从小鼠胚胎中分离出hec和前hsc诱导造血干细胞。然而,早期发育阶段的信号需求在很大程度上仍然不明确。在这项研究中,我们试图确定E9.5 hec体外诱导造血干细胞所需的关键信号因子。E9.5小鼠胚胎的转录组学分析检测到hec中骨形态发生蛋白(BMP)信号的激活。培养系统中的BMP4处理增强了多系造血集落的产生和长期再生的造血干细胞,这一点在集落形成和移植试验中得到了证实。此外,能够形成造血干细胞的早期hec表达BMP4受体。这些结果表明,BMP4在促进早期hec可移植HSC的出现中发挥了关键作用,并为HSC发展的阶段特异性需求提供了见解。这些发现可能有助于建立多能干细胞体外衍生造血干细胞的条件。
{"title":"3034 – IN VITRO INDUCTION OF HEMATOPOIETIC STEM CELLS FROM EARLY HEMOGENIC ENDOTHELIAL CELLS","authors":"Mariko Tsuruda ,&nbsp;Saori Morino-Koga ,&nbsp;Xueyu Zhao ,&nbsp;Shingo Usuki ,&nbsp;Kei-ichiro Yasunaga ,&nbsp;Tomomasa Yokomizo ,&nbsp;Ryuichi Nishinakamura ,&nbsp;Toshio Suda ,&nbsp;Minetaro Ogawa","doi":"10.1016/j.exphem.2025.104975","DOIUrl":"10.1016/j.exphem.2025.104975","url":null,"abstract":"<div><div>During embryogenesis, hematopoietic stem cells (HSCs) arise from hemogenic endothelial cells (HECs). HECs enter endothelial-to-hematopoietic transition (EHT) and differentiate into HSCs via pre-HSCs. Previously, we reported that two cytokines and feeder cells were sufficient to induce HSCs from HECs and pre-HSCs isolated from mouse embryos at embryonic day 10.5 (E10.5). However, the signaling requirements at earlier developmental stages remain largely undefined. In this study, we sought to identify the key signaling factors required to induce HSCs from E9.5 HECs in vitro. Transcriptomic profiling of E9.5 mouse embryos detected activation of bone morphogenetic protein (BMP) signaling in HECs. BMP4 treatment in the culture system enhanced the generation of multilineage hematopoietic colonies and long-term repopulating HSCs, as confirmed using colony-forming and transplantation assays. Furthermore, early-stage HECs capable of forming HSCs expressed the BMP4 receptor. These results suggest that BMP4 plays a key role in promoting the emergence of transplantable HSCs from early HECs and provides insight into stage-specific requirements for HSC development. These findings may contribute to establishing conditions for in vitro derivation of HSCs from pluripotent stem cells.</div></div>","PeriodicalId":12202,"journal":{"name":"Experimental hematology","volume":"151 ","pages":"Article 104975"},"PeriodicalIF":2.1,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145620399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3035 – HEMOGENIC GASTRULOIDS CAPTURE DYNAMIC SPECIFICATION OF HE AND EHT AND INFORM RULES OF HSCS FORMATION 3035 -造血原胃样蛋白捕获he和ht的动态规格,并告知造血干细胞形成的规则
IF 2.1 4区 医学 Q2 HEMATOLOGY Pub Date : 2025-11-01 DOI: 10.1016/j.exphem.2025.104976
Ylenia Cicirò , Denise Ragusa , Ayona Johns , Camilla Cerutti , Cristina Pina
Emergence of definitive hematopoietic stem cells (HSCs) during embryonic development is underpinned by the crucial process of endothelial-to-hematopoietic transition (EHT). Therein, HSCs and progenitors are specified from a specialized subset of endothelial cells termed hemogenic endothelium (HE). These cells reside in the aorta-gonad-mesonephros (AGM) region, namely in the ventral wall of the dorsal aorta, and acquire hematopoietic potential through an incompletely characterized morphogenetic and transcriptional programming process that generates the first self-renewing, multilineage HSCs.
We made use of our previously described mouse embryonic stem cell-based 3D hemogenic gastruloid (haemGx) to dissect the dynamic specification of HE and decipher the morpho-molecular reconfiguration that underpins EHT. The haemGx model recapitulates temporally accurate emergence of CD31+CD34+Kit+ cells with HE characteristics, followed by sequential waves of CD41+ and CD45+ cells, corresponding to hematopoietic progenitors.
We integrated high-content microscopy, flow cytometry, and scRNA-seq, coupled to gene regulatory network analysis, to comprehensively capture the transcriptional dynamics of EHT and model HSCs’ emergence in silico. We further dissected intrinsic and extrinsic contributions to EHT and hematopoietic specification by establishing a novel endothelial culture system derived from haemGx and exploring endothelial and hematopoietic formation with different cellular compositions.
Our integrated approach provides a mechanistically tractable model of HE specification and EHT. Comprehensive inference of the dynamic rules underpinning the earliest events in hematopoietic specification will be pivotal to the design of high-efficiency protocols for in vitro production of HSCs.
胚胎发育过程中确定的造血干细胞(hsc)的出现是由内皮到造血转化(EHT)的关键过程支撑的。其中,造血干细胞和祖细胞是由内皮细胞称为造血内皮(HE)的特殊亚群指定的。这些细胞位于主动脉-性腺-中肾(AGM)区域,即背主动脉腹侧壁,并通过不完全表征的形态发生和转录编程过程获得造血潜能,从而产生第一批自我更新的多系造血干细胞。我们利用先前描述的基于小鼠胚胎干细胞的3D造血原胃样蛋白(haemGx)来解剖HE的动态规范,并破译支撑EHT的形态-分子重构。haemGx模型概括了具有HE特征的CD31+CD34+Kit+细胞的时间准确出现,随后是CD41+和CD45+细胞的顺序波,对应于造血祖细胞。我们整合了高含量显微镜、流式细胞术和scRNA-seq,结合基因调控网络分析,全面捕捉了EHT和模型hsc在硅中的出现的转录动力学。我们通过建立源自haemGx的新型内皮培养系统,并探索不同细胞组成的内皮和造血形成,进一步剖析了EHT和造血规范的内在和外在贡献。我们的集成方法提供了HE规范和EHT的机械可处理模型。全面推断造血规范中支持最早事件的动态规则对于设计体外造血干细胞生产的高效方案至关重要。
{"title":"3035 – HEMOGENIC GASTRULOIDS CAPTURE DYNAMIC SPECIFICATION OF HE AND EHT AND INFORM RULES OF HSCS FORMATION","authors":"Ylenia Cicirò ,&nbsp;Denise Ragusa ,&nbsp;Ayona Johns ,&nbsp;Camilla Cerutti ,&nbsp;Cristina Pina","doi":"10.1016/j.exphem.2025.104976","DOIUrl":"10.1016/j.exphem.2025.104976","url":null,"abstract":"<div><div>Emergence of definitive hematopoietic stem cells (HSCs) during embryonic development is underpinned by the crucial process of endothelial-to-hematopoietic transition (EHT). Therein, HSCs and progenitors are specified from a specialized subset of endothelial cells termed hemogenic endothelium (HE). These cells reside in the aorta-gonad-mesonephros (AGM) region, namely in the ventral wall of the dorsal aorta, and acquire hematopoietic potential through an incompletely characterized morphogenetic and transcriptional programming process that generates the first self-renewing, multilineage HSCs.</div><div>We made use of our previously described mouse embryonic stem cell-based 3D hemogenic gastruloid (haemGx) to dissect the dynamic specification of HE and decipher the morpho-molecular reconfiguration that underpins EHT. The haemGx model recapitulates temporally accurate emergence of CD31+CD34+Kit+ cells with HE characteristics, followed by sequential waves of CD41+ and CD45+ cells, corresponding to hematopoietic progenitors.</div><div>We integrated high-content microscopy, flow cytometry, and scRNA-seq, coupled to gene regulatory network analysis, to comprehensively capture the transcriptional dynamics of EHT and model HSCs’ emergence in silico. We further dissected intrinsic and extrinsic contributions to EHT and hematopoietic specification by establishing a novel endothelial culture system derived from haemGx and exploring endothelial and hematopoietic formation with different cellular compositions.</div><div>Our integrated approach provides a mechanistically tractable model of HE specification and EHT. Comprehensive inference of the dynamic rules underpinning the earliest events in hematopoietic specification will be pivotal to the design of high-efficiency protocols for in vitro production of HSCs.</div></div>","PeriodicalId":12202,"journal":{"name":"Experimental hematology","volume":"151 ","pages":"Article 104976"},"PeriodicalIF":2.1,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145620400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3036 – AUTOPHAGY REGULATES THE MATURATION OF HEMATOPOIETIC PRECURSORS IN THE EMBRYO 3036 -自噬调节胚胎中造血前体的成熟
IF 2.1 4区 医学 Q2 HEMATOLOGY Pub Date : 2025-11-01 DOI: 10.1016/j.exphem.2025.104977
Yumin Liu , Sifan Luo , Yuehang Chen , Zhuan Li
An understanding of the mechanisms regulating embryonic hematopoietic stem cell (HSC) development would facilitate their regeneration. The aorta gonad-mesonephros (AGM) region is the site for HSC production from hemogenic endothelial cells (HEC) through a process termed endothelial-to-hematopoietic transition (EHT). Although several regulators are involved in this process, the role of autophagy (macroautophagy) in preliver hematopoiesis remains unclear. Here, we investigated how autophagy influences the EHT in the AGM region. First, we showed that different states of autophagy existed in hematopoietic precursors and correlated with hematopoietic potential based on the RFP-EGFP-LC3 (LC3R/G) mouse model. The treatment with autophagy inhibitors resulted in the reduction of hematopoietic progenitors, indicating the possible roles of autophagy in hematopoietic development.
Furthermore, we generated Atg5 conditional knockout (cKO) mice (Vec-Cre; Atg5fl/fl) to disrupt autophagy. By combining LC3R/G with cKO embryos, we detected that the autophagic process was blocked in the hematopoietic-related cells, validating the role of Atg5 in autophagy. Atg5 deficiency impaired hematopoietic stem/progenitor cell (HSPC) function in the AGM region, expanded hematopoietic clusters, and increased immature pre-HSC I production. Trajectory analysis further demonstrated the delay of pre-HSC I maturation, collectively indicating disrupted EHT. Comparison analysis of transcriptomics between the cKO and control group showed increased interactions of Ncl-Ptn and Ncl-Mdk. Our functional and immunostaining data confirmed the altered nucleolin (NCL) distribution and the rescue role played by AS1411 (the aptamer of NCL) in the HEC and pre-HSC I fractions. In summary, we have discovered that autophagy regulates the EHT process and the maturation of pre-HSC from HEC, possibly through NCL distribution.
了解胚胎造血干细胞(HSC)发育的调控机制有助于其再生。主动脉性腺-中肾(AGM)区是造血内皮细胞(HEC)通过内皮-造血转化(EHT)过程产生造血干细胞的部位。虽然有几种调节因子参与这一过程,但自噬(巨噬)在肝前造血中的作用尚不清楚。在这里,我们研究了自噬如何影响AGM区域的EHT。首先,我们基于RFP-EGFP-LC3 (LC3R/G)小鼠模型发现造血前体细胞中存在不同状态的自噬,并与造血潜能相关。使用自噬抑制剂治疗导致造血祖细胞减少,提示自噬在造血发育中的可能作用。此外,我们制造了Atg5条件敲除(cKO)小鼠(Vec-Cre; Atg5fl/fl)来破坏自噬。通过将LC3R/G与cKO胚胎结合,我们检测到造血相关细胞的自噬过程被阻断,验证了Atg5在自噬中的作用。Atg5缺陷损害了AGM区域的造血干细胞/祖细胞(HSPC)功能,扩大了造血集群,增加了未成熟的前hsc I的产生。轨迹分析进一步表明,hsc I前成熟延迟,共同表明EHT中断。cKO与对照组的转录组学比较分析显示,Ncl-Ptn和Ncl-Mdk的相互作用增加。我们的功能和免疫染色数据证实了核仁蛋白(NCL)分布的改变以及AS1411 (NCL适配体)在HEC和预hsc I中发挥的拯救作用。综上所述,我们发现自噬可能通过NCL分布调节HEC的EHT过程和预hsc的成熟。
{"title":"3036 – AUTOPHAGY REGULATES THE MATURATION OF HEMATOPOIETIC PRECURSORS IN THE EMBRYO","authors":"Yumin Liu ,&nbsp;Sifan Luo ,&nbsp;Yuehang Chen ,&nbsp;Zhuan Li","doi":"10.1016/j.exphem.2025.104977","DOIUrl":"10.1016/j.exphem.2025.104977","url":null,"abstract":"<div><div>An understanding of the mechanisms regulating embryonic hematopoietic stem cell (HSC) development would facilitate their regeneration. The aorta gonad-mesonephros (AGM) region is the site for HSC production from hemogenic endothelial cells (HEC) through a process termed endothelial-to-hematopoietic transition (EHT). Although several regulators are involved in this process, the role of autophagy (macroautophagy) in preliver hematopoiesis remains unclear. Here, we investigated how autophagy influences the EHT in the AGM region. First, we showed that different states of autophagy existed in hematopoietic precursors and correlated with hematopoietic potential based on the RFP-EGFP-LC3 (LC3R/G) mouse model. The treatment with autophagy inhibitors resulted in the reduction of hematopoietic progenitors, indicating the possible roles of autophagy in hematopoietic development.</div><div>Furthermore, we generated Atg5 conditional knockout (cKO) mice (Vec-Cre; Atg5fl/fl) to disrupt autophagy. By combining LC3R/G with cKO embryos, we detected that the autophagic process was blocked in the hematopoietic-related cells, validating the role of Atg5 in autophagy. Atg5 deficiency impaired hematopoietic stem/progenitor cell (HSPC) function in the AGM region, expanded hematopoietic clusters, and increased immature pre-HSC I production. Trajectory analysis further demonstrated the delay of pre-HSC I maturation, collectively indicating disrupted EHT. Comparison analysis of transcriptomics between the cKO and control group showed increased interactions of Ncl-Ptn and Ncl-Mdk. Our functional and immunostaining data confirmed the altered nucleolin (NCL) distribution and the rescue role played by AS1411 (the aptamer of NCL) in the HEC and pre-HSC I fractions. In summary, we have discovered that autophagy regulates the EHT process and the maturation of pre-HSC from HEC, possibly through NCL distribution.</div></div>","PeriodicalId":12202,"journal":{"name":"Experimental hematology","volume":"151 ","pages":"Article 104977"},"PeriodicalIF":2.1,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145620401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
1019 – DYING TO REGENERATE: ENDOGENOUS MECHANISMS OF TISSUE REPAIR IN THE THYMUS 死亡再生:胸腺组织修复的内源性机制
IF 2.1 4区 医学 Q2 HEMATOLOGY Pub Date : 2025-11-01 DOI: 10.1016/j.exphem.2025.104899
Jarrod Dudakov
The thymus, which is the primary site of T cell development, is extremely sensitive to insult but also has a remarkable capacity for endogenous repair. However, even though there is continual thymic involution and regeneration in response to everyday insults like stress and infection, profound thymic damage, such as ionizing radiation, leads to prolonged T cell lymphopenia. One approach to developing therapies to boost thymic function after radiation injury is to understand and exploit the processes underlying endogenous repair.
We have identified that the balance of cell death detection is crucial for triggering endogenous regenerative responses in the thymus. Specifically, immunologically silent apoptosis (which is abundant in thymocytes during steady-state) is suppressive to the regenerative program, but in contrast, after thymic damage, a switch toward immunogenic cell death (ICD) can promote regeneration. Importantly, many of these pathways can be therapeutically targeted to improve thymic recovery after radiation injury. However, induction of ICD (and specifically the cleavage of caspase-1) also leads to the activation of proinflammatory factors such as IL-18 and IL-1β. Although IL-1β did not seem to impact regeneration after injury, IL-18 limited repair by stimulating NK cells and their cytotoxic program, which targets thymic epithelial cells, which are crucial for supporting T cell development. Notably, this proinflammatory axis is not the only limitation to thymus repair, with aging-associated epithelial remodeling also contributing to blunted regenerative responses with age.
Together, these studies not only further defined the cellular and molecular regulators of thymic damage and repair after injury but also demonstrated the critical need for balancing proregenerative and suppressive signals in developing optimal therapies for thymus recovery and T cell reconstitution.
胸腺是T细胞发育的主要部位,对损伤极其敏感,但也具有显著的内源性修复能力。然而,即使胸腺持续退化和再生,以应对日常的伤害,如压力和感染,严重的胸腺损伤,如电离辐射,导致长期的T细胞淋巴减少。研究放射损伤后增强胸腺功能的方法之一是了解和利用内源性修复的潜在过程。我们已经确定,细胞死亡检测的平衡是触发胸腺内源性再生反应的关键。具体来说,免疫沉默细胞凋亡(在稳定状态下大量存在于胸腺细胞中)抑制再生程序,但相反,胸腺损伤后,向免疫原性细胞死亡(ICD)的转变可以促进再生。重要的是,许多这些途径可以靶向治疗,以改善放射损伤后的胸腺恢复。然而,ICD的诱导(特别是caspase-1的裂解)也会导致IL-18和IL-1β等促炎因子的激活。虽然IL-1β似乎不影响损伤后的再生,但IL-18通过刺激NK细胞及其细胞毒性程序限制修复,其目标是胸腺上皮细胞,这对支持T细胞的发育至关重要。值得注意的是,这种促炎轴并不是胸腺修复的唯一限制,衰老相关的上皮重塑也会导致再生反应随着年龄的增长而减弱。总之,这些研究不仅进一步定义了胸腺损伤和损伤后修复的细胞和分子调节因子,而且还表明,在开发胸腺恢复和T细胞重建的最佳疗法时,平衡促再生和抑制信号是至关重要的。
{"title":"1019 – DYING TO REGENERATE: ENDOGENOUS MECHANISMS OF TISSUE REPAIR IN THE THYMUS","authors":"Jarrod Dudakov","doi":"10.1016/j.exphem.2025.104899","DOIUrl":"10.1016/j.exphem.2025.104899","url":null,"abstract":"<div><div>The thymus, which is the primary site of T cell development, is extremely sensitive to insult but also has a remarkable capacity for endogenous repair. However, even though there is continual thymic involution and regeneration in response to everyday insults like stress and infection, profound thymic damage, such as ionizing radiation, leads to prolonged T cell lymphopenia. One approach to developing therapies to boost thymic function after radiation injury is to understand and exploit the processes underlying endogenous repair.</div><div>We have identified that the balance of cell death detection is crucial for triggering endogenous regenerative responses in the thymus. Specifically, immunologically silent apoptosis (which is abundant in thymocytes during steady-state) is suppressive to the regenerative program, but in contrast, after thymic damage, a switch toward immunogenic cell death (ICD) can promote regeneration. Importantly, many of these pathways can be therapeutically targeted to improve thymic recovery after radiation injury. However, induction of ICD (and specifically the cleavage of caspase-1) also leads to the activation of proinflammatory factors such as IL-18 and IL-1β. Although IL-1β did not seem to impact regeneration after injury, IL-18 limited repair by stimulating NK cells and their cytotoxic program, which targets thymic epithelial cells, which are crucial for supporting T cell development. Notably, this proinflammatory axis is not the only limitation to thymus repair, with aging-associated epithelial remodeling also contributing to blunted regenerative responses with age.</div><div>Together, these studies not only further defined the cellular and molecular regulators of thymic damage and repair after injury but also demonstrated the critical need for balancing proregenerative and suppressive signals in developing optimal therapies for thymus recovery and T cell reconstitution.</div></div>","PeriodicalId":12202,"journal":{"name":"Experimental hematology","volume":"151 ","pages":"Article 104899"},"PeriodicalIF":2.1,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145620386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Experimental hematology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1